HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

BACKGROUND: Recently, a Risk of Ovarian Malignancy Algorithm (ROMA) utilising human epididymis secretory protein 4 (HE4) and CA125 successfully classified patients as presenting a high or low risk for epithelial ovarian cancer (EOC). We validated this algorithm in an independent prospective study. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Gorp, T, Cadron, I, Despierre, E, Daemen, A, Leunen, K, Amant, F, Timmerman, D, De Moor, B, Vergote, I
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048204/
https://www.ncbi.nlm.nih.gov/pubmed/21304524
http://dx.doi.org/10.1038/sj.bjc.6606092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048204/
https://www.ncbi.nlm.nih.gov/pubmed/21304524
http://dx.doi.org/10.1038/sj.bjc.6606092

Ejemplares similares